Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Investigational New Drugs|September 20, 2001
Phase II trial of 9-aminocamptothecin as a 72-h infusion in cutaneous T-cell lymphomaA Argiris, P Heald, T Kuzel, et al.
Surgery|December 1, 1996
Mechanism of technetium 99m sestamibi parathyroid imaging and the possible role of p-glycoproteinB K Mitchell, E A Cornelius, S Zoghbi, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Trifluoperazine as a modulator of multidrug resistance in refractory breast cancerJ R Murren, H J Durivage, A C Buzaid, et al.
American Journal of Clinical Oncology|June 1, 1991
A phase II trial of cyclosporin A in the treatment of refractory metastatic colorectal cancerJ R Murren, S Ganpule, A Sarris, et al.
Cancer Journal (Sudbury, Mass.)|October 19, 2000
Phase I and pharmacokinetic study of novobiocin in combination with VP-16 in patients with refractory malignanciesJ R Murren, S A DiStasio, A Lorico, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2000
Dose escalation and pharmacokinetic study of irinotecan in combination with paclitaxel in patients with advanced cancerJ R Murren, K Peccerillo, S A DiStasio, et al.
American Journal of Clinical Oncology|June 1, 1994
Cisplatin, doxorubicin, mitomycin C, and 5-fluorouracil for the treatment of metastatic non-small cell lung cancer. Limited activity of an aggressive chemotherapy regimenJ R Murren, H J Durivage, A H Rosenberg, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Biochemical modulation of 5-fluorouracil with brequinar: results of a phase I studyA C Buzaid, G Pizzorno, J C Marsh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 12, 2009
Phase II trial of docetaxel-irinotecan combination in advanced esophageal cancerB Burtness, M Gibson, B Egleston, et al.
Oncology Research|January 1, 1993
A phase II trial of mitomycin C, 5-fluorouracil and radiation therapy in the treatment of unresectable non-small cell lung cancerJ R Murren, S Ganpule, R Papac, et al.
Pageof 4